tiprankstipranks

Stephanie Lovell Insider Profile

4 Followers
Stephanie Lovell, Director at Cyclerion Therapeutics, holds 2.87K shares in TransMedics Group (Ticker: TMDX), holds 2.42K shares in Cyclerion Therapeutics (Ticker: CYCN). Most recently, Stephanie Lovell Sold ― shares of TransMedics Group on Mar 06, 2026 for an estimated value of $178.50K.
tipranks
Stephanie Lovell

Stephanie Lovell
Cyclerion Therapeutics (CYCN)
Director

Ranked #58,626 out of 106,487 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-5.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$288K
98.73%
1.27%
A breakdown of Stephanie Lovell's holdings

Insider Roles

TransMedics Group
(TMDX)
Director
Cyclerion Therapeutics
(CYCN)
Director
Roles that Stephanie Lovell holds in companies

Most Profitable Insider Trade

Stock:
TransMedics Group
(TMDX)
Rating:Informative Sell
Date:Mar 06, 2026 - Today
Return:+4.70%
The most profitable trade made by Stephanie Lovell

Stephanie Lovell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cyclerion Therapeutics
Apr 03, 2019
Director
Uninformative Buy
$3.64K
TransMedics Group
Mar 06, 2026
Director
Informative Sell
178.50K
$283.88K
List of latest transactions for each holding click on a transaction to see Stephanie Lovell's performance on stock

Stephanie Lovell insider profile FAQ

What is the percentage of profitable transactions made by Stephanie Lovell?
The percentage of profitable transactions made by Stephanie Lovell is 50%.
    What is the average return per transaction made by Stephanie Lovell?
    The average return per transaction made by Stephanie Lovell is -5.20%.
      What stocks does Stephanie Lovell hold?
      Stephanie Lovell holds: CYCN, TMDX stocks.
        What was Stephanie Lovell’s latest transaction?
        Stephanie Lovell latest transaction was an Informative Sell of $178.50K.
          What was Stephanie Lovell's most profitable transaction?
          Stephanie Lovell’s most profitable transaction was an Informative Sell of TMDX stock on March 6, 2026. The return on the trade was 4.70%.
            What is Stephanie Lovell's role in Cyclerion Therapeutics?
            Stephanie Lovell's role in Cyclerion Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.